Surveillance/Survey Reports
Objectives: To support region-specific injury prevention strategies, this study analyzed the incidence and characteristics of severe trauma, nontraumatic serious injuries, and mass casualty incidents across the Gyeongnam region (Busan, Ulsan, and Gyeongnam) using data from the 2023 Community-Based Severe Trauma Surveillance.
Methods: By referencing the 2023 Community-Based Severe Trauma Surveillance statistics from the Korea Disease Control and Prevention Agency, the study examined injury characteristics in Gyeongnam and compared them with national figures.
Results: The rate of severe trauma rose from 1,188 (15.4 per 100,000) the prior year to 1,252 cases (16.4 per 100,000); the highest incidence rates were observed in patients aged 80 and older (Busan, 25.1; Ulsan, 37.7; Gyeongnam, 39.7). Transport accidents were the most prevalent incidents in Ulsan (52.4%) and Gyeongnam (55.0%), while falls/slips predominated in Busan (55.2%). Case fatality rates fell across Busan (57.9%→52.3%), Ulsan (48.5%→46.5%), and Gyeongnam (62.0%→57.7%), while disability rates rose in each of these regions (Busan, 83.2%→84.8%; Ulsan, 79.1%→87.9%; Gyeongnam, 70.7%→76.2%). Nontraumatic serious injuries dropped to 2,363 incidents (30.9 per 100,000) from a previous count of 2,400 (31.1); the highest incidence rates were observed among those aged 80 and older (Busan, 58.3; Ulsan, 59.6; Gyeongnam, 69.6). Self-harm/suicide ranked as the primary underlying cause (Busan, 80.3%; Ulsan, 66.5%; Gyeongnam, 59.3%). Notably, Busan posted the highest rate nationwide. Mass casualty incidents accounted for 622 cases (8.1 per 100,000), primarily due to vehicle accidents (Busan, 73.7%; Ulsan, 64.8%; Gyeongnam, 78.4%).
Conclusions: Injury patterns differ by location. Busan necessitates reinforced fall prevention and mental health interventions; Ulsan requires targeted strategies for severe trauma, mass casualty management, and mitigation of nontraumatic injury fatality; and Gyeongnam demands healthcare infrastructure improvements to reduce incidence, case fatality, and disability rates. Consequently, localized management frameworks tailored to growing elderly populations are warranted across the Gyeongnam area.
Methods: By referencing the 2023 Community-Based Severe Trauma Surveillance statistics from the Korea Disease Control and Prevention Agency, the study examined injury characteristics in Gyeongnam and compared them with national figures.
Results: The rate of severe trauma rose from 1,188 (15.4 per 100,000) the prior year to 1,252 cases (16.4 per 100,000); the highest incidence rates were observed in patients aged 80 and older (Busan, 25.1; Ulsan, 37.7; Gyeongnam, 39.7). Transport accidents were the most prevalent incidents in Ulsan (52.4%) and Gyeongnam (55.0%), while falls/slips predominated in Busan (55.2%). Case fatality rates fell across Busan (57.9%→52.3%), Ulsan (48.5%→46.5%), and Gyeongnam (62.0%→57.7%), while disability rates rose in each of these regions (Busan, 83.2%→84.8%; Ulsan, 79.1%→87.9%; Gyeongnam, 70.7%→76.2%). Nontraumatic serious injuries dropped to 2,363 incidents (30.9 per 100,000) from a previous count of 2,400 (31.1); the highest incidence rates were observed among those aged 80 and older (Busan, 58.3; Ulsan, 59.6; Gyeongnam, 69.6). Self-harm/suicide ranked as the primary underlying cause (Busan, 80.3%; Ulsan, 66.5%; Gyeongnam, 59.3%). Notably, Busan posted the highest rate nationwide. Mass casualty incidents accounted for 622 cases (8.1 per 100,000), primarily due to vehicle accidents (Busan, 73.7%; Ulsan, 64.8%; Gyeongnam, 78.4%).
Conclusions: Injury patterns differ by location. Busan necessitates reinforced fall prevention and mental health interventions; Ulsan requires targeted strategies for severe trauma, mass casualty management, and mitigation of nontraumatic injury fatality; and Gyeongnam demands healthcare infrastructure improvements to reduce incidence, case fatality, and disability rates. Consequently, localized management frameworks tailored to growing elderly populations are warranted across the Gyeongnam area.
Public Health Weekly Report 2026; 19(30): 1229-1250
Review & Perspective
Objectives: This report evaluates the U.S. public health policy shifts enacted by the 2025 Trump administration and assesses their implications for global health cooperation, evidence-based policymaking, and the Republic of Korea’s health security strategy.
Methods: This study employed a narrative review and policy analysis based on documents published between January 2025 and May 2026. Data were collected from official U.S. federal agency sources and major media outlets using specific search terms, including “Trump administration” and “public health policy.” After screening for policy relevance and reliability, the reviewed literature was synthesized and qualitatively analyzed into four main topics: agency reorganization and budget cuts, immunization policy adjustments, data-driven research environments, and global health cooperation.
Results: To improve efficiency and realign priorities, the U.S. federal government restructured public health governance by streamlining U.S. Department of Health and Human Services agencies from 28 to 15 and reducing staff. Immunization policy shifted toward emphasizing individual choice, reducing the number of routine recommended vaccines from 17 to 11 by excluding rotavirus, hepatitis A and B, meningococcal, coronavirus disease 2019, and influenza vaccines. Multilateral cooperation also declined as the Centers for Disease Control and Prevention decentralized data management, the U.S. withdrew from the World Health Organization, and the United States Agency for International Development was dissolved, shifting the focus toward bilateral memoranda of understanding. However, these swift transformations triggered sharp institutional resistance, including judicial injunctions, government shutdowns, and state-level policy fragmentation.
Conclusions: Alterations to these frameworks and guidelines may reduce the predictability of global infectious disease surveillance and cooperation. Consequently, the Korea Disease Control and Prevention Agency must enhance independent global surveillance, develop science-based communication to sustain vaccine confidence, and diversify multi- and bilateral cooperation networks to keep pace with evolving global health dynamics.
Methods: This study employed a narrative review and policy analysis based on documents published between January 2025 and May 2026. Data were collected from official U.S. federal agency sources and major media outlets using specific search terms, including “Trump administration” and “public health policy.” After screening for policy relevance and reliability, the reviewed literature was synthesized and qualitatively analyzed into four main topics: agency reorganization and budget cuts, immunization policy adjustments, data-driven research environments, and global health cooperation.
Results: To improve efficiency and realign priorities, the U.S. federal government restructured public health governance by streamlining U.S. Department of Health and Human Services agencies from 28 to 15 and reducing staff. Immunization policy shifted toward emphasizing individual choice, reducing the number of routine recommended vaccines from 17 to 11 by excluding rotavirus, hepatitis A and B, meningococcal, coronavirus disease 2019, and influenza vaccines. Multilateral cooperation also declined as the Centers for Disease Control and Prevention decentralized data management, the U.S. withdrew from the World Health Organization, and the United States Agency for International Development was dissolved, shifting the focus toward bilateral memoranda of understanding. However, these swift transformations triggered sharp institutional resistance, including judicial injunctions, government shutdowns, and state-level policy fragmentation.
Conclusions: Alterations to these frameworks and guidelines may reduce the predictability of global infectious disease surveillance and cooperation. Consequently, the Korea Disease Control and Prevention Agency must enhance independent global surveillance, develop science-based communication to sustain vaccine confidence, and diversify multi- and bilateral cooperation networks to keep pace with evolving global health dynamics.
Public Health Weekly Report 2026; 19(30): 1251-1280
QuickStats
Public Health Weekly Report 2026; 19(30): 1281-1282
Full Text
Cite
Share
PMC
About
Archives
Instruction
Publishing Policies
e-Submission
Contact Us
